Cargando…
The perverse impact of external reference pricing (ERP): a comparison of orphan drugs affordability in 12 European countries. A call for policy change
Objective: The study compared the relative cost differences of similar orphan drugs among high and low GDP countries in Europe: Bulgaria, France, Germany, Greece, Hungary, Italy, Norway, Poland, Romania, Spain, Sweden, UK. Methods: Annual treatment costs per patient were calculated. Relative costs w...
Autores principales: | Young, K. E., Soussi, I., Toumi, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Routledge
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645904/ https://www.ncbi.nlm.nih.gov/pubmed/29081920 http://dx.doi.org/10.1080/20016689.2017.1369817 |
Ejemplares similares
-
A comparative study of orphan drug prices in Europe
por: Young, Katherine Eve, et al.
Publicado: (2017) -
Affordability of antimicrobials for animals and humans in Vietnam: A call to revise pricing policies
por: Carrique-Mas, Juan, et al.
Publicado: (2019) -
Overview of external reference pricing systems in Europe
por: Rémuzat, Cécile, et al.
Publicado: (2015) -
Cellulose Perversions
por: Canejo, João P., et al.
Publicado: (2013) -
Prices of Orphan Drugs in Four Western European Countries Before and After Market Exclusivity Expiry: A Cross-Country Comparison of List Prices and Purchase Prices
por: Dane, Aniek, et al.
Publicado: (2023)